Inspire Medical Systems, Inc.
INSP
$126.10
$1.561.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 522.69% | 352.96% | 200.86% | 114.63% | 63.92% |
| Total Depreciation and Amortization | 183.15% | 130.15% | 88.18% | 63.50% | 47.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.14% | 28.85% | 30.47% | 34.37% | 43.93% |
| Change in Net Operating Assets | -87.40% | 7.53% | -193.65% | -4,713.16% | -1,349.78% |
| Cash from Operations | 229.01% | 428.32% | 193.87% | -12.73% | 51.73% |
| Capital Expenditure | -13.50% | -65.57% | -116.38% | -159.52% | -171.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 78.75% | 72.71% | -79.19% | -2,950.20% | -2,622.26% |
| Cash from Investing | 69.37% | 61.63% | -83.91% | -5,463.36% | -1,319.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 11.88% | -10.72% | -11.53% | -92.62% | -89.64% |
| Repurchase of Common Stock | -839.31% | -367.22% | -610.49% | -604.86% | -945.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1,650.80% | -475.58% | -75.66% | -99.51% | -96.18% |
| Foreign Exchange rate Adjustments | -178.57% | -171.95% | 100.78% | -220.75% | -163.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.43% | 86.18% | -107.47% | -199.48% | -211.67% |